Form 4: ClearPoint Neuro Chief Business Officer Reports Routine Stock Disposition for Tax Obligations

ClearPoint Neuro, Inc.'s Chief Business Officer, L. Jeremy Stigall, reported the disposition of 3,561 shares of common stock valued at $13.29 per share to cover tax withholding obligations related to restricted stock vesting.

Summary

• L. Jeremy Stigall, Chief Business Officer of ClearPoint Neuro, Inc. (CLPT), reported a transaction on June 10, 2025.
• The transaction involved the disposition of 3,561 shares of ClearPoint Neuro common stock.
• The shares were disposed of at a price of $13.29 per share.
• This disposition was made to satisfy applicable tax withholding obligations in connection with the vesting of restricted stock.
• Following this transaction, Mr. Stigall beneficially owns 70,747 shares of ClearPoint Neuro common stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, non-discretionary transaction for tax purposes related to executive compensation, which is a common occurrence and does not indicate a change in company fundamentals or insider sentiment towards the stock.

Positives

• The underlying event, the vesting of restricted stock, represents a form of compensation for the Chief Business Officer, indicating continued alignment of executive incentives with shareholder interests.

Negatives

• The disposition of shares was solely for tax withholding purposes and does not represent a discretionary sale by the insider, thus it is not inherently negative for the company or its stock.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing is a routine insider transaction report common across all industries when executives' restricted stock vests and shares are withheld to cover tax liabilities. It does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: This is a routine transaction and is unlikely to have a significant direct impact on shareholders. It reflects a standard aspect of executive compensation.
• Employees: The vesting of restricted stock is a common form of employee compensation, aligning executive interests with company performance.

Key Dates

Keywords

ClearPoint Neuro, CLPT, Form 4, Insider Transaction, Stock Disposition, Tax Withholding, Restricted Stock, Executive Compensation, L. Jeremy Stigall